Comparison of salivary epidermal growth factor in patients with recurrent aphthous stomatitis, smokers, and healthy individuals

Background: Recurrent aphthous stomatitis (RAS) is one of the most common oral ulcerative diseases with unknown etiology. Epidermal growth factor (EGF) has been suggested to play a similar role in RAS. Therefore, this study investigated the salivary EGF level in patients with RAS, the patients witho...

Full description

Bibliographic Details
Main Authors: Fatemeh Rezaei, Erfan Hosseini, Farzad Rezaei
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2019;volume=8;issue=8;spage=2587;epage=2591;aulast=Rezaei
_version_ 1828176530137677824
author Fatemeh Rezaei
Erfan Hosseini
Farzad Rezaei
author_facet Fatemeh Rezaei
Erfan Hosseini
Farzad Rezaei
author_sort Fatemeh Rezaei
collection DOAJ
description Background: Recurrent aphthous stomatitis (RAS) is one of the most common oral ulcerative diseases with unknown etiology. Epidermal growth factor (EGF) has been suggested to play a similar role in RAS. Therefore, this study investigated the salivary EGF level in patients with RAS, the patients without RAS, and smokers. Materials and Methods: A total of 91 samples were recruited in this case-control study: 30 RAS patients, 30 controls, and 31 smokers. Age and gender were matched in the groups. In the case group, the salivary sample was taken during the infection and remission periods. Salivary EGF concentration was measured by Crystal Dibiotic assay (made in China) using ELISA technique. Finally, the data were analyzed by SPSS software (Version 18.0, Inc., Chicago, IL, USA). Results: The results of paired t-test showed no statistically significant difference in salivary EGF between the infection and remission periods (P = 0.987). ANOVA test showed a statistically significant difference in EGF between the study groups (P < 0.001), as the mean salivary EGF was significantly lower in the smokers than the case and control groups during the infection and remission periods. Conclusion: The present study showed a lower level of salivary EGF in the smokers without a history of RAS. There was no statistically significant difference between the infection and remission periods in salivary EGF in the patients with RAS. Furthermore, salivary EGF showed no statistically significant difference between the patients with RAS and the controls.
first_indexed 2024-04-12T04:46:05Z
format Article
id doaj.art-ba42197a816e4775aab1c4c414e4774f
institution Directory Open Access Journal
issn 2249-4863
language English
last_indexed 2024-04-12T04:46:05Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj.art-ba42197a816e4775aab1c4c414e4774f2022-12-22T03:47:30ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632019-01-01882587259110.4103/jfmpc.jfmpc_397_19Comparison of salivary epidermal growth factor in patients with recurrent aphthous stomatitis, smokers, and healthy individualsFatemeh RezaeiErfan HosseiniFarzad RezaeiBackground: Recurrent aphthous stomatitis (RAS) is one of the most common oral ulcerative diseases with unknown etiology. Epidermal growth factor (EGF) has been suggested to play a similar role in RAS. Therefore, this study investigated the salivary EGF level in patients with RAS, the patients without RAS, and smokers. Materials and Methods: A total of 91 samples were recruited in this case-control study: 30 RAS patients, 30 controls, and 31 smokers. Age and gender were matched in the groups. In the case group, the salivary sample was taken during the infection and remission periods. Salivary EGF concentration was measured by Crystal Dibiotic assay (made in China) using ELISA technique. Finally, the data were analyzed by SPSS software (Version 18.0, Inc., Chicago, IL, USA). Results: The results of paired t-test showed no statistically significant difference in salivary EGF between the infection and remission periods (P = 0.987). ANOVA test showed a statistically significant difference in EGF between the study groups (P < 0.001), as the mean salivary EGF was significantly lower in the smokers than the case and control groups during the infection and remission periods. Conclusion: The present study showed a lower level of salivary EGF in the smokers without a history of RAS. There was no statistically significant difference between the infection and remission periods in salivary EGF in the patients with RAS. Furthermore, salivary EGF showed no statistically significant difference between the patients with RAS and the controls.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2019;volume=8;issue=8;spage=2587;epage=2591;aulast=RezaeiEpidermal growth factorrecurrent aphthous stomatitissalivasmoking
spellingShingle Fatemeh Rezaei
Erfan Hosseini
Farzad Rezaei
Comparison of salivary epidermal growth factor in patients with recurrent aphthous stomatitis, smokers, and healthy individuals
Journal of Family Medicine and Primary Care
Epidermal growth factor
recurrent aphthous stomatitis
saliva
smoking
title Comparison of salivary epidermal growth factor in patients with recurrent aphthous stomatitis, smokers, and healthy individuals
title_full Comparison of salivary epidermal growth factor in patients with recurrent aphthous stomatitis, smokers, and healthy individuals
title_fullStr Comparison of salivary epidermal growth factor in patients with recurrent aphthous stomatitis, smokers, and healthy individuals
title_full_unstemmed Comparison of salivary epidermal growth factor in patients with recurrent aphthous stomatitis, smokers, and healthy individuals
title_short Comparison of salivary epidermal growth factor in patients with recurrent aphthous stomatitis, smokers, and healthy individuals
title_sort comparison of salivary epidermal growth factor in patients with recurrent aphthous stomatitis smokers and healthy individuals
topic Epidermal growth factor
recurrent aphthous stomatitis
saliva
smoking
url http://www.jfmpc.com/article.asp?issn=2249-4863;year=2019;volume=8;issue=8;spage=2587;epage=2591;aulast=Rezaei
work_keys_str_mv AT fatemehrezaei comparisonofsalivaryepidermalgrowthfactorinpatientswithrecurrentaphthousstomatitissmokersandhealthyindividuals
AT erfanhosseini comparisonofsalivaryepidermalgrowthfactorinpatientswithrecurrentaphthousstomatitissmokersandhealthyindividuals
AT farzadrezaei comparisonofsalivaryepidermalgrowthfactorinpatientswithrecurrentaphthousstomatitissmokersandhealthyindividuals